Claire Johnston

2.5k total citations
8 papers, 127 citations indexed

About

Claire Johnston is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Claire Johnston has authored 8 papers receiving a total of 127 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Claire Johnston's work include Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (1 paper) and Advanced Breast Cancer Therapies (1 paper). Claire Johnston is often cited by papers focused on Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (1 paper) and Advanced Breast Cancer Therapies (1 paper). Claire Johnston collaborates with scholars based in United Kingdom, United States and Germany. Claire Johnston's co-authors include Brendan Healy, Chris J. Norbury, Leon Bosquée, Emma Cattell, Martin Reck, Joachim von Pawel, S. Murray Yule, Anthe S. Zandvliet, Denis Talbot and Alwin D. R. Huitema and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and BMJ.

In The Last Decade

Claire Johnston

8 papers receiving 125 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Johnston United Kingdom 7 50 40 26 16 13 8 127
Jérémie Zerbit France 7 34 0.7× 47 1.2× 33 1.3× 32 2.0× 6 0.5× 10 154
Donald Brooks United States 7 44 0.9× 50 1.3× 23 0.9× 15 0.9× 5 0.4× 14 184
Natsuki Koike Japan 10 49 1.0× 20 0.5× 35 1.3× 38 2.4× 6 0.5× 27 366
Antonio Pellegrino Italy 5 36 0.7× 42 1.1× 14 0.5× 10 0.6× 3 0.2× 6 213
Mary Beth Nierengarten United States 7 53 1.1× 59 1.5× 10 0.4× 26 1.6× 21 1.6× 80 202
Charan Thej Reddy Vegivinti United States 6 22 0.4× 33 0.8× 33 1.3× 14 0.9× 13 1.0× 27 109
Patricia Esperón Uruguay 7 42 0.8× 22 0.6× 5 0.2× 14 0.9× 12 0.9× 30 162
Ali Arash Anoushirvani Iran 8 40 0.8× 34 0.8× 18 0.7× 12 0.8× 8 0.6× 20 118
Dorota Oszutowska–Mazurek Poland 5 58 1.2× 17 0.4× 7 0.3× 10 0.6× 16 1.2× 14 125
Khayry Al‐Shami Jordan 5 34 0.7× 25 0.6× 12 0.5× 7 0.4× 6 0.5× 11 120

Countries citing papers authored by Claire Johnston

Since Specialization
Citations

This map shows the geographic impact of Claire Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Johnston more than expected).

Fields of papers citing papers by Claire Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Johnston. The network helps show where Claire Johnston may publish in the future.

Co-authorship network of co-authors of Claire Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Johnston. A scholar is included among the top collaborators of Claire Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Johnston. Claire Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Johnston, Claire, et al.. (2022). Immunity and infectivity in covid-19. BMJ. 378. e061402–e061402. 14 indexed citations
2.
Johnston, Claire & Brendan Healy. (2020). Interpretation of COVID-19 PCR testing- what surgeons need to know. British journal of surgery. 107(10). e367–e367. 2 indexed citations
3.
Johnston, Claire, et al.. (2020). Hospital‐in‐the‐Home experience of first 23 COVID‐19 patients at a regional NSW hospital. Internal Medicine Journal. 50(10). 1271–1273. 9 indexed citations
4.
Holborow, Abigail, Hibo Asad, Claire Johnston, et al.. (2020). The clinical sensitivity of a single SARS-CoV-2 upper respiratory tract RT-PCR test for diagnosing COVID-19 using convalescent antibody as a comparator. Clinical Medicine. 20(6). e209–e211. 18 indexed citations
5.
Plummer, Ruth, T.R. Jeffry Evans, David Alan Anthoney, et al.. (2012). A phase Ib dose-escalation study of eribulin mesylate in combination with capecitabine in patients with advanced/metastatic cancer.. Journal of Clinical Oncology. 30(15_suppl). 2552–2552. 6 indexed citations
6.
Daniele, Gennaro, Malcolm Ranson, Montserrat Blanco-Codesido, et al.. (2012). Phase I dose-finding study of golvatinib (E7050), a c-Met and Eph receptor targeted multi-kinase inhibitor, administered orally QD to patients with advanced solid tumors.. Journal of Clinical Oncology. 30(15_suppl). 3030–3030. 9 indexed citations
7.
Talbot, Denis, Joachim von Pawel, Emma Cattell, et al.. (2007). A Randomized Phase II Pharmacokinetic and Pharmacodynamic Study of Indisulam as Second-Line Therapy in Patients with Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 13(6). 1816–1822. 52 indexed citations
8.
Shea, M. Tracie, Stephen A. Bernard, Joseph M. Wiley, et al.. (1995). A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable or metastatic cancer.. PubMed. 22(5 Suppl 12). 80–5. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026